Home / Inspections / 1039561

FDA Inspection 1039561 — Oxygen Development, L.L.C.

Oxygen Development, L.L.C. — FEI 3009461317

The FDA completed an inspection of Oxygen Development, L.L.C. on January 17, 2018 in Palm Springs, FL. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
January 17, 2018
Fiscal Year
2018
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Palm Springs, FL (United States)

Facility

Other inspections at this facility

  • 1295654 (NAI Tue May 19 2026 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1250745 (VAI Thu Sep 11 2025 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1042460 (NAI Fri Jan 19 2018 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 857278 (NAI Fri Nov 22 2013 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 824681 (VAI Fri Mar 29 2013 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources